Shandong Wit Dyne Health Co.,Ltd. (SHE:000915)
28.06
+0.02 (0.07%)
May 20, 2026, 1:25 PM CST
Shandong Wit Dyne Health Revenue
Shandong Wit Dyne Health had revenue of 412.27M CNY in the quarter ending March 31, 2026, a decrease of -33.10%. This brings the company's revenue in the last twelve months to 2.02B, down -7.10% year-over-year. In the year 2025, Shandong Wit Dyne Health had annual revenue of 2.23B with 4.40% growth.
Revenue (ttm)
2.02B
Revenue Growth
-7.10%
P/S Ratio
3.25
Revenue / Employee
1.18M
Employees
1,719
Market Cap
6.57B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.23B | 93.89M | 4.40% |
| Dec 31, 2024 | 2.13B | -349.67M | -14.08% |
| Dec 31, 2023 | 2.48B | 143.09M | 6.11% |
| Dec 31, 2022 | 2.34B | 313.93M | 15.49% |
| Jan 1, 2022 | 2.03B | 206.11M | 11.32% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jan 1, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Northeast Pharmaceutical Group | 7.13B |
| KPC Pharmaceuticals,Inc. | 5.80B |
| Cisen Pharmaceutical | 3.37B |
| Zhejiang Tianyu Pharmaceutical | 3.11B |
| Guizhou Bailing Group Pharmaceutical | 2.93B |
| HARBIN GLORIA PHARMACEUTICALS Co., LTD | 2.12B |
| Beijing Sun-Novo Pharmaceutical Research | 1.19B |
| Beijing SL Pharmaceutical | 591.59M |